Brian J. Donnelly
Chief Commerical Officer, Myriad Genetics.
Companies
- Myriad GeneticsChief Commerical Officer May 1, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Myriad Genetics MYGN573,363 shares2$2.4M at $4.16Sep 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 11, 2026Granted 5,000 shares at $3.94 of Myriad Genetics3
- May 1, 2026Shares withheld for tax 55,975 shares at $4.80 of Myriad Genetics4
- Mar 12, 2026Granted 226,804 shares of Myriad Genetics5
- May 1, 2025Granted 127,629 shares of Myriad Genetics6
- May 1, 2025Granted 269,905 shares of Myriad Genetics6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 12, 2026
- 4SEC EDGARForm 4 filed May 4, 2026
- 5SEC EDGARForm 4 filed Mar 16, 2026
- 6SEC EDGARForm 4 filed May 2, 2025